Rights and permissions
About this article
Cite this article
Psychotropic costs shifted during US capping programme. Pharmacoecon. Outcomes News 13, 16 (1994). https://doi.org/10.1007/BF03293630
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03293630